Skip to main content
. 2021 Aug 11;8(1):e000719. doi: 10.1136/bmjgast-2021-000719

Figure 4.

Figure 4

Secondary outcome—estimated probabilities of death from gastric cancer stratified by proton pump inhibitor (PPI) use. The risk of death from gastric cancer after time zero (ie, 365 days after percutaneous coronary intervention (PCI)) was significantly higher with PPI use (HR 4.18; 95% CI 1.09 to 16.08, p=0.037).